Eupraxia Pharmaceuticals Inc. is trading 5.2% down at $6.12 amid a broad market sell-off that is pressuring risk and growth names.
- The decline appears aligned with wider risk-off sentiment and general weakness across equities rather than a new development specific to the company.
- There are no fresh company-specific headlines, regulatory filings, or analyst actions reported today.